RT Journal Article
SR Electronic
T1 Which prophylactic aspirin?
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 7
OP 8
DO 10.1136/dtb.1997.3517
VO 35
IS 1
YR 1997
UL http://dtb.bmj.com/content/35/1/7.abstract
AB Relevant BNF sections: 2.9, 4.7.1Low doses of aspirin are now a standard part of the management of patients with thromboembolic disease.1,2 One risk of taking even low doses is bleeding from the gut, and various aspirin formulations are marketed with claims that they reduce this problem. In this article we review the formulations available and consider their relative safety.